126 related articles for article (PubMed ID: 11364689)
1. Efavirenz (SUSTIVA) expanded access begins October 1.
James JS
AIDS Treat News; 1997 Sep; (No 279):1-2. PubMed ID: 11364689
[TBL] [Abstract][Full Text] [Related]
2. DMP 266 now available.
Gilden D
GMHC Treat Issues; 1997 Sep; 11(9):5-6. PubMed ID: 11364751
[TBL] [Abstract][Full Text] [Related]
3. Efavirenz (Sustiva) expanded access now to 400 CD4.
AIDS Treat News; 1998 Jan; (No 286):5. PubMed ID: 11364952
[TBL] [Abstract][Full Text] [Related]
4. DMP-266 and adefovir dipivoxil: 2 new AIDS drugs available to patients without treatment options.
Baker R
BETA; 1997 Sep; ():6-7. PubMed ID: 11364709
[TBL] [Abstract][Full Text] [Related]
5. Expanded access programs.
Treat Rev; 1997 Nov; (No 26-27):12. PubMed ID: 11364931
[TBL] [Abstract][Full Text] [Related]
6. Expanded access.
Notes Undergr; 1997 Nov; (No 36):6. PubMed ID: 11365207
[TBL] [Abstract][Full Text] [Related]
7. DMP 266 (Sustiva) expanded access.
Vazquez E; Whitfield L
Posit Aware; 1997; 8(6):12. PubMed ID: 11364850
[TBL] [Abstract][Full Text] [Related]
8. Efavirenz expanded access broadened.
Highleyman L
BETA; 1998 Apr; ():3. PubMed ID: 11365262
[TBL] [Abstract][Full Text] [Related]
9. More expanded access for DMP 266.
Vazquez E
Posit Aware; 1998; 9(2):15. PubMed ID: 11365220
[TBL] [Abstract][Full Text] [Related]
10. Some competition for 1592.
GMHC Treat Issues; 1997; 11(4/5):10-1. PubMed ID: 11364373
[TBL] [Abstract][Full Text] [Related]
11. New expanded access drugs for use in combination therapy.
Notes Undergr; 1998; (No 37):suppl 1-2. PubMed ID: 11365823
[TBL] [Abstract][Full Text] [Related]
12. Efavirenz expanded access.
Highleyman L
BETA; 1998 Jan; ():4. PubMed ID: 11364975
[TBL] [Abstract][Full Text] [Related]
13. Options when HIV treatments fail.
Treat Rev; 1998; (No 28):7-9. PubMed ID: 11365426
[TBL] [Abstract][Full Text] [Related]
14. Efavirenz (Sustiva) available through patient assistance program.
AIDS Treat News; 1998 Nov; (No 306):4. PubMed ID: 11365962
[TBL] [Abstract][Full Text] [Related]
15. Don't mix Sustiva with Fortovase.
Posit Aware; 1998; 9(5):17. PubMed ID: 11365885
[TBL] [Abstract][Full Text] [Related]
16. Clinical history of efavirenz.
Ruiz N
Int J Clin Pract Suppl; 1999 Jun; 103():3-7. PubMed ID: 10622035
[TBL] [Abstract][Full Text] [Related]
17. Efavirenz (Sustiva): oral liquid expanded access program for children and adolescents ages 3-16.
AIDS Treat News; 2000 May; (342):4. PubMed ID: 12870459
[TBL] [Abstract][Full Text] [Related]
18. Broadened access to Sustiva.
Bornhoeft MA
Body Posit; 1998 Jan; 11(1):13. PubMed ID: 11365007
[TBL] [Abstract][Full Text] [Related]
19. Experience with efavirenz in end-stage renal disease.
Das S; Ghanem M; Huengsberg M
Int J STD AIDS; 2004 Feb; 15(2):143. PubMed ID: 15006080
[No Abstract] [Full Text] [Related]
20. Dupont pharmaceuticals study 006 for Sustiva.
Bartlett JG
Hopkins HIV Rep; 1998 Sep; 10(5):1. PubMed ID: 11365772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
